Gastrointestinal Drugs Market Size, Share & Trends Analysis Report By Drug Class Type (Acid Neutralizers, Antidiarrheal and Laxatives, Antiemetic and Antinauseants, Anti-inflammatory Drugs, Biologics, Others (Antispasmodic etc.)), By Route of Administration (Oral, Intravenous, Rectal), By Disorder Type (Gastro-esophageal Reflux Disease, Inflammatory Bowel Disease, Irritable Bowel Syndrome), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Mitiksha Koul | Format: | Report Code: SR4659DR | Pages: 110

Market Segmentation

  1. Gastrointestinal Drugs Market, By Drug Class Type 2022-2034 (USD MILLION/ Units)
    1. Acid Neutralizers
    2. Antidiarrheal and Laxatives
    3. Antiemetic and Antinauseants
    4. Anti-inflammatory Drugs
    5. Biologics
    6. Others (Antispasmodic etc.)
  2. Gastrointestinal Drugs Market, By Route of Administration 2022-2034 (USD MILLION/ Units)
    1. Oral
    2. Intravenous
    3. Rectal
  3. Gastrointestinal Drugs Market, By Disorder Type 2022-2034 (USD MILLION/ Units)
    1. Gastro-esophageal Reflux Disease
    2. Inflammatory Bowel Disease
    3. Irritable Bowel Syndrome
  4. Gastrointestinal Drugs Market, By Distribution Channel 2022-2034 (USD MILLION/ Units)
    1. Hospital Pharmacies
    2. Retail Pharmacies
    3. Online Pharmacies
  5. Regional Gastrointestinal Drugs Market
    1. North America
      1. North America Gastrointestinal Drugs Market By Drug Class Type 2022-2034 (USD MILLION/ Units)
        1. Acid Neutralizers
        2. Antidiarrheal and Laxatives
        3. Antiemetic and Antinauseants
        4. Anti-inflammatory Drugs
        5. Biologics
        6. Others (Antispasmodic etc.)
      2. North America Gastrointestinal Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous
        3. Rectal
      3. North America Gastrointestinal Drugs Market By Disorder Type 2022-2034 (USD MILLION/ Units)
        1. Gastro-esophageal Reflux Disease
        2. Inflammatory Bowel Disease
        3. Irritable Bowel Syndrome
      4. North America Gastrointestinal Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
      5. U.S. Gastrointestinal Drugs Market
        1. U.S. Gastrointestinal Drugs Market By Drug Class Type 2022-2034 (USD MILLION/ Units)
          1. Acid Neutralizers
          2. Antidiarrheal and Laxatives
          3. Antiemetic and Antinauseants
          4. Anti-inflammatory Drugs
          5. Biologics
          6. Others (Antispasmodic etc.)
        2. U.S. Gastrointestinal Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Intravenous
          3. Rectal
        3. U.S. Gastrointestinal Drugs Market By Disorder Type 2022-2034 (USD MILLION/ Units)
          1. Gastro-esophageal Reflux Disease
          2. Inflammatory Bowel Disease
          3. Irritable Bowel Syndrome
        4. U.S. Gastrointestinal Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacies
          3. Online Pharmacies
      6. Canada Gastrointestinal Drugs Market
        1. Canada Gastrointestinal Drugs Market By Drug Class Type 2022-2034 (USD MILLION/ Units)
          1. Acid Neutralizers
          2. Antidiarrheal and Laxatives
          3. Antiemetic and Antinauseants
          4. Anti-inflammatory Drugs
          5. Biologics
          6. Others (Antispasmodic etc.)
        2. Canada Gastrointestinal Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Intravenous
          3. Rectal
        3. Canada Gastrointestinal Drugs Market By Disorder Type 2022-2034 (USD MILLION/ Units)
          1. Gastro-esophageal Reflux Disease
          2. Inflammatory Bowel Disease
          3. Irritable Bowel Syndrome
        4. Canada Gastrointestinal Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacies
          3. Online Pharmacies
    2. Europe
      1. Europe Gastrointestinal Drugs Market By Drug Class Type 2022-2034 (USD MILLION/ Units)
        1. Acid Neutralizers
        2. Antidiarrheal and Laxatives
        3. Antiemetic and Antinauseants
        4. Anti-inflammatory Drugs
        5. Biologics
        6. Others (Antispasmodic etc.)
      2. Europe Gastrointestinal Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous
        3. Rectal
      3. Europe Gastrointestinal Drugs Market By Disorder Type 2022-2034 (USD MILLION/ Units)
        1. Gastro-esophageal Reflux Disease
        2. Inflammatory Bowel Disease
        3. Irritable Bowel Syndrome
      4. Europe Gastrointestinal Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
      5. U.K. Gastrointestinal Drugs Market
        1. U.K. Gastrointestinal Drugs Market By Drug Class Type 2022-2034 (USD MILLION/ Units)
          1. Acid Neutralizers
          2. Antidiarrheal and Laxatives
          3. Antiemetic and Antinauseants
          4. Anti-inflammatory Drugs
          5. Biologics
          6. Others (Antispasmodic etc.)
        2. U.K. Gastrointestinal Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Intravenous
          3. Rectal
        3. U.K. Gastrointestinal Drugs Market By Disorder Type 2022-2034 (USD MILLION/ Units)
          1. Gastro-esophageal Reflux Disease
          2. Inflammatory Bowel Disease
          3. Irritable Bowel Syndrome
        4. U.K. Gastrointestinal Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacies
          3. Online Pharmacies
      6. Germany Gastrointestinal Drugs Market
        1. Germany Gastrointestinal Drugs Market By Drug Class Type 2022-2034 (USD MILLION/ Units)
          1. Acid Neutralizers
          2. Antidiarrheal and Laxatives
          3. Antiemetic and Antinauseants
          4. Anti-inflammatory Drugs
          5. Biologics
          6. Others (Antispasmodic etc.)
        2. Germany Gastrointestinal Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Intravenous
          3. Rectal
        3. Germany Gastrointestinal Drugs Market By Disorder Type 2022-2034 (USD MILLION/ Units)
          1. Gastro-esophageal Reflux Disease
          2. Inflammatory Bowel Disease
          3. Irritable Bowel Syndrome
        4. Germany Gastrointestinal Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacies
          3. Online Pharmacies
      7. France Gastrointestinal Drugs Market
        1. France Gastrointestinal Drugs Market By Drug Class Type 2022-2034 (USD MILLION/ Units)
          1. Acid Neutralizers
          2. Antidiarrheal and Laxatives
          3. Antiemetic and Antinauseants
          4. Anti-inflammatory Drugs
          5. Biologics
          6. Others (Antispasmodic etc.)
        2. France Gastrointestinal Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Intravenous
          3. Rectal
        3. France Gastrointestinal Drugs Market By Disorder Type 2022-2034 (USD MILLION/ Units)
          1. Gastro-esophageal Reflux Disease
          2. Inflammatory Bowel Disease
          3. Irritable Bowel Syndrome
        4. France Gastrointestinal Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacies
          3. Online Pharmacies
      8. Spain Gastrointestinal Drugs Market
        1. Spain Gastrointestinal Drugs Market By Drug Class Type 2022-2034 (USD MILLION/ Units)
          1. Acid Neutralizers
          2. Antidiarrheal and Laxatives
          3. Antiemetic and Antinauseants
          4. Anti-inflammatory Drugs
          5. Biologics
          6. Others (Antispasmodic etc.)
        2. Spain Gastrointestinal Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Intravenous
          3. Rectal
        3. Spain Gastrointestinal Drugs Market By Disorder Type 2022-2034 (USD MILLION/ Units)
          1. Gastro-esophageal Reflux Disease
          2. Inflammatory Bowel Disease
          3. Irritable Bowel Syndrome
        4. Spain Gastrointestinal Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacies
          3. Online Pharmacies
      9. Italy Gastrointestinal Drugs Market
        1. Italy Gastrointestinal Drugs Market By Drug Class Type 2022-2034 (USD MILLION/ Units)
          1. Acid Neutralizers
          2. Antidiarrheal and Laxatives
          3. Antiemetic and Antinauseants
          4. Anti-inflammatory Drugs
          5. Biologics
          6. Others (Antispasmodic etc.)
        2. Italy Gastrointestinal Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Intravenous
          3. Rectal
        3. Italy Gastrointestinal Drugs Market By Disorder Type 2022-2034 (USD MILLION/ Units)
          1. Gastro-esophageal Reflux Disease
          2. Inflammatory Bowel Disease
          3. Irritable Bowel Syndrome
        4. Italy Gastrointestinal Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacies
          3. Online Pharmacies
      10. Russia Gastrointestinal Drugs Market
        1. Russia Gastrointestinal Drugs Market By Drug Class Type 2022-2034 (USD MILLION/ Units)
          1. Acid Neutralizers
          2. Antidiarrheal and Laxatives
          3. Antiemetic and Antinauseants
          4. Anti-inflammatory Drugs
          5. Biologics
          6. Others (Antispasmodic etc.)
        2. Russia Gastrointestinal Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Intravenous
          3. Rectal
        3. Russia Gastrointestinal Drugs Market By Disorder Type 2022-2034 (USD MILLION/ Units)
          1. Gastro-esophageal Reflux Disease
          2. Inflammatory Bowel Disease
          3. Irritable Bowel Syndrome
        4. Russia Gastrointestinal Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacies
          3. Online Pharmacies
      11. Nordic Gastrointestinal Drugs Market
        1. Nordic Gastrointestinal Drugs Market By Drug Class Type 2022-2034 (USD MILLION/ Units)
          1. Acid Neutralizers
          2. Antidiarrheal and Laxatives
          3. Antiemetic and Antinauseants
          4. Anti-inflammatory Drugs
          5. Biologics
          6. Others (Antispasmodic etc.)
        2. Nordic Gastrointestinal Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Intravenous
          3. Rectal
        3. Nordic Gastrointestinal Drugs Market By Disorder Type 2022-2034 (USD MILLION/ Units)
          1. Gastro-esophageal Reflux Disease
          2. Inflammatory Bowel Disease
          3. Irritable Bowel Syndrome
        4. Nordic Gastrointestinal Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacies
          3. Online Pharmacies
      12. Benelux Gastrointestinal Drugs Market
        1. Benelux Gastrointestinal Drugs Market By Drug Class Type 2022-2034 (USD MILLION/ Units)
          1. Acid Neutralizers
          2. Antidiarrheal and Laxatives
          3. Antiemetic and Antinauseants
          4. Anti-inflammatory Drugs
          5. Biologics
          6. Others (Antispasmodic etc.)
        2. Benelux Gastrointestinal Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Intravenous
          3. Rectal
        3. Benelux Gastrointestinal Drugs Market By Disorder Type 2022-2034 (USD MILLION/ Units)
          1. Gastro-esophageal Reflux Disease
          2. Inflammatory Bowel Disease
          3. Irritable Bowel Syndrome
        4. Benelux Gastrointestinal Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacies
          3. Online Pharmacies
      13. Rest of Europe Gastrointestinal Drugs Market
        1. Rest of Europe Gastrointestinal Drugs Market By Drug Class Type 2022-2034 (USD MILLION/ Units)
          1. Acid Neutralizers
          2. Antidiarrheal and Laxatives
          3. Antiemetic and Antinauseants
          4. Anti-inflammatory Drugs
          5. Biologics
          6. Others (Antispasmodic etc.)
        2. Rest of Europe Gastrointestinal Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Intravenous
          3. Rectal
        3. Rest of Europe Gastrointestinal Drugs Market By Disorder Type 2022-2034 (USD MILLION/ Units)
          1. Gastro-esophageal Reflux Disease
          2. Inflammatory Bowel Disease
          3. Irritable Bowel Syndrome
        4. Rest of Europe Gastrointestinal Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacies
          3. Online Pharmacies
    3. APAC
      1. APAC Gastrointestinal Drugs Market By Drug Class Type 2022-2034 (USD MILLION/ Units)
        1. Acid Neutralizers
        2. Antidiarrheal and Laxatives
        3. Antiemetic and Antinauseants
        4. Anti-inflammatory Drugs
        5. Biologics
        6. Others (Antispasmodic etc.)
      2. APAC Gastrointestinal Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous
        3. Rectal
      3. APAC Gastrointestinal Drugs Market By Disorder Type 2022-2034 (USD MILLION/ Units)
        1. Gastro-esophageal Reflux Disease
        2. Inflammatory Bowel Disease
        3. Irritable Bowel Syndrome
      4. APAC Gastrointestinal Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
      5. China Gastrointestinal Drugs Market
        1. China Gastrointestinal Drugs Market By Drug Class Type 2022-2034 (USD MILLION/ Units)
          1. Acid Neutralizers
          2. Antidiarrheal and Laxatives
          3. Antiemetic and Antinauseants
          4. Anti-inflammatory Drugs
          5. Biologics
          6. Others (Antispasmodic etc.)
        2. China Gastrointestinal Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Intravenous
          3. Rectal
        3. China Gastrointestinal Drugs Market By Disorder Type 2022-2034 (USD MILLION/ Units)
          1. Gastro-esophageal Reflux Disease
          2. Inflammatory Bowel Disease
          3. Irritable Bowel Syndrome
        4. China Gastrointestinal Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacies
          3. Online Pharmacies
      6. Korea Gastrointestinal Drugs Market
        1. Korea Gastrointestinal Drugs Market By Drug Class Type 2022-2034 (USD MILLION/ Units)
          1. Acid Neutralizers
          2. Antidiarrheal and Laxatives
          3. Antiemetic and Antinauseants
          4. Anti-inflammatory Drugs
          5. Biologics
          6. Others (Antispasmodic etc.)
        2. Korea Gastrointestinal Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Intravenous
          3. Rectal
        3. Korea Gastrointestinal Drugs Market By Disorder Type 2022-2034 (USD MILLION/ Units)
          1. Gastro-esophageal Reflux Disease
          2. Inflammatory Bowel Disease
          3. Irritable Bowel Syndrome
        4. Korea Gastrointestinal Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacies
          3. Online Pharmacies
      7. Japan Gastrointestinal Drugs Market
        1. Japan Gastrointestinal Drugs Market By Drug Class Type 2022-2034 (USD MILLION/ Units)
          1. Acid Neutralizers
          2. Antidiarrheal and Laxatives
          3. Antiemetic and Antinauseants
          4. Anti-inflammatory Drugs
          5. Biologics
          6. Others (Antispasmodic etc.)
        2. Japan Gastrointestinal Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Intravenous
          3. Rectal
        3. Japan Gastrointestinal Drugs Market By Disorder Type 2022-2034 (USD MILLION/ Units)
          1. Gastro-esophageal Reflux Disease
          2. Inflammatory Bowel Disease
          3. Irritable Bowel Syndrome
        4. Japan Gastrointestinal Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacies
          3. Online Pharmacies
      8. India Gastrointestinal Drugs Market
        1. India Gastrointestinal Drugs Market By Drug Class Type 2022-2034 (USD MILLION/ Units)
          1. Acid Neutralizers
          2. Antidiarrheal and Laxatives
          3. Antiemetic and Antinauseants
          4. Anti-inflammatory Drugs
          5. Biologics
          6. Others (Antispasmodic etc.)
        2. India Gastrointestinal Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Intravenous
          3. Rectal
        3. India Gastrointestinal Drugs Market By Disorder Type 2022-2034 (USD MILLION/ Units)
          1. Gastro-esophageal Reflux Disease
          2. Inflammatory Bowel Disease
          3. Irritable Bowel Syndrome
        4. India Gastrointestinal Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacies
          3. Online Pharmacies
      9. Australia Gastrointestinal Drugs Market
        1. Australia Gastrointestinal Drugs Market By Drug Class Type 2022-2034 (USD MILLION/ Units)
          1. Acid Neutralizers
          2. Antidiarrheal and Laxatives
          3. Antiemetic and Antinauseants
          4. Anti-inflammatory Drugs
          5. Biologics
          6. Others (Antispasmodic etc.)
        2. Australia Gastrointestinal Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Intravenous
          3. Rectal
        3. Australia Gastrointestinal Drugs Market By Disorder Type 2022-2034 (USD MILLION/ Units)
          1. Gastro-esophageal Reflux Disease
          2. Inflammatory Bowel Disease
          3. Irritable Bowel Syndrome
        4. Australia Gastrointestinal Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacies
          3. Online Pharmacies
      10. Taiwan Gastrointestinal Drugs Market
        1. Taiwan Gastrointestinal Drugs Market By Drug Class Type 2022-2034 (USD MILLION/ Units)
          1. Acid Neutralizers
          2. Antidiarrheal and Laxatives
          3. Antiemetic and Antinauseants
          4. Anti-inflammatory Drugs
          5. Biologics
          6. Others (Antispasmodic etc.)
        2. Taiwan Gastrointestinal Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Intravenous
          3. Rectal
        3. Taiwan Gastrointestinal Drugs Market By Disorder Type 2022-2034 (USD MILLION/ Units)
          1. Gastro-esophageal Reflux Disease
          2. Inflammatory Bowel Disease
          3. Irritable Bowel Syndrome
        4. Taiwan Gastrointestinal Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacies
          3. Online Pharmacies
      11. South East Asia Gastrointestinal Drugs Market
        1. South East Asia Gastrointestinal Drugs Market By Drug Class Type 2022-2034 (USD MILLION/ Units)
          1. Acid Neutralizers
          2. Antidiarrheal and Laxatives
          3. Antiemetic and Antinauseants
          4. Anti-inflammatory Drugs
          5. Biologics
          6. Others (Antispasmodic etc.)
        2. South East Asia Gastrointestinal Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Intravenous
          3. Rectal
        3. South East Asia Gastrointestinal Drugs Market By Disorder Type 2022-2034 (USD MILLION/ Units)
          1. Gastro-esophageal Reflux Disease
          2. Inflammatory Bowel Disease
          3. Irritable Bowel Syndrome
        4. South East Asia Gastrointestinal Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacies
          3. Online Pharmacies
      12. Rest of Asia-Pacific Gastrointestinal Drugs Market
        1. Rest of Asia-Pacific Gastrointestinal Drugs Market By Drug Class Type 2022-2034 (USD MILLION/ Units)
          1. Acid Neutralizers
          2. Antidiarrheal and Laxatives
          3. Antiemetic and Antinauseants
          4. Anti-inflammatory Drugs
          5. Biologics
          6. Others (Antispasmodic etc.)
        2. Rest of Asia-Pacific Gastrointestinal Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Intravenous
          3. Rectal
        3. Rest of Asia-Pacific Gastrointestinal Drugs Market By Disorder Type 2022-2034 (USD MILLION/ Units)
          1. Gastro-esophageal Reflux Disease
          2. Inflammatory Bowel Disease
          3. Irritable Bowel Syndrome
        4. Rest of Asia-Pacific Gastrointestinal Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacies
          3. Online Pharmacies
    4. Middle East and Africa
      1. Middle East and Africa Gastrointestinal Drugs Market By Drug Class Type 2022-2034 (USD MILLION/ Units)
        1. Acid Neutralizers
        2. Antidiarrheal and Laxatives
        3. Antiemetic and Antinauseants
        4. Anti-inflammatory Drugs
        5. Biologics
        6. Others (Antispasmodic etc.)
      2. Middle East and Africa Gastrointestinal Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous
        3. Rectal
      3. Middle East and Africa Gastrointestinal Drugs Market By Disorder Type 2022-2034 (USD MILLION/ Units)
        1. Gastro-esophageal Reflux Disease
        2. Inflammatory Bowel Disease
        3. Irritable Bowel Syndrome
      4. Middle East and Africa Gastrointestinal Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
      5. UAE Gastrointestinal Drugs Market
        1. UAE Gastrointestinal Drugs Market By Drug Class Type 2022-2034 (USD MILLION/ Units)
          1. Acid Neutralizers
          2. Antidiarrheal and Laxatives
          3. Antiemetic and Antinauseants
          4. Anti-inflammatory Drugs
          5. Biologics
          6. Others (Antispasmodic etc.)
        2. UAE Gastrointestinal Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Intravenous
          3. Rectal
        3. UAE Gastrointestinal Drugs Market By Disorder Type 2022-2034 (USD MILLION/ Units)
          1. Gastro-esophageal Reflux Disease
          2. Inflammatory Bowel Disease
          3. Irritable Bowel Syndrome
        4. UAE Gastrointestinal Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacies
          3. Online Pharmacies
      6. Turkey Gastrointestinal Drugs Market
        1. Turkey Gastrointestinal Drugs Market By Drug Class Type 2022-2034 (USD MILLION/ Units)
          1. Acid Neutralizers
          2. Antidiarrheal and Laxatives
          3. Antiemetic and Antinauseants
          4. Anti-inflammatory Drugs
          5. Biologics
          6. Others (Antispasmodic etc.)
        2. Turkey Gastrointestinal Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Intravenous
          3. Rectal
        3. Turkey Gastrointestinal Drugs Market By Disorder Type 2022-2034 (USD MILLION/ Units)
          1. Gastro-esophageal Reflux Disease
          2. Inflammatory Bowel Disease
          3. Irritable Bowel Syndrome
        4. Turkey Gastrointestinal Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacies
          3. Online Pharmacies
      7. Saudi Arabia Gastrointestinal Drugs Market
        1. Saudi Arabia Gastrointestinal Drugs Market By Drug Class Type 2022-2034 (USD MILLION/ Units)
          1. Acid Neutralizers
          2. Antidiarrheal and Laxatives
          3. Antiemetic and Antinauseants
          4. Anti-inflammatory Drugs
          5. Biologics
          6. Others (Antispasmodic etc.)
        2. Saudi Arabia Gastrointestinal Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Intravenous
          3. Rectal
        3. Saudi Arabia Gastrointestinal Drugs Market By Disorder Type 2022-2034 (USD MILLION/ Units)
          1. Gastro-esophageal Reflux Disease
          2. Inflammatory Bowel Disease
          3. Irritable Bowel Syndrome
        4. Saudi Arabia Gastrointestinal Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacies
          3. Online Pharmacies
      8. South Africa Gastrointestinal Drugs Market
        1. South Africa Gastrointestinal Drugs Market By Drug Class Type 2022-2034 (USD MILLION/ Units)
          1. Acid Neutralizers
          2. Antidiarrheal and Laxatives
          3. Antiemetic and Antinauseants
          4. Anti-inflammatory Drugs
          5. Biologics
          6. Others (Antispasmodic etc.)
        2. South Africa Gastrointestinal Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Intravenous
          3. Rectal
        3. South Africa Gastrointestinal Drugs Market By Disorder Type 2022-2034 (USD MILLION/ Units)
          1. Gastro-esophageal Reflux Disease
          2. Inflammatory Bowel Disease
          3. Irritable Bowel Syndrome
        4. South Africa Gastrointestinal Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacies
          3. Online Pharmacies
      9. Egypt Gastrointestinal Drugs Market
        1. Egypt Gastrointestinal Drugs Market By Drug Class Type 2022-2034 (USD MILLION/ Units)
          1. Acid Neutralizers
          2. Antidiarrheal and Laxatives
          3. Antiemetic and Antinauseants
          4. Anti-inflammatory Drugs
          5. Biologics
          6. Others (Antispasmodic etc.)
        2. Egypt Gastrointestinal Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Intravenous
          3. Rectal
        3. Egypt Gastrointestinal Drugs Market By Disorder Type 2022-2034 (USD MILLION/ Units)
          1. Gastro-esophageal Reflux Disease
          2. Inflammatory Bowel Disease
          3. Irritable Bowel Syndrome
        4. Egypt Gastrointestinal Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacies
          3. Online Pharmacies
      10. Nigeria Gastrointestinal Drugs Market
        1. Nigeria Gastrointestinal Drugs Market By Drug Class Type 2022-2034 (USD MILLION/ Units)
          1. Acid Neutralizers
          2. Antidiarrheal and Laxatives
          3. Antiemetic and Antinauseants
          4. Anti-inflammatory Drugs
          5. Biologics
          6. Others (Antispasmodic etc.)
        2. Nigeria Gastrointestinal Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Intravenous
          3. Rectal
        3. Nigeria Gastrointestinal Drugs Market By Disorder Type 2022-2034 (USD MILLION/ Units)
          1. Gastro-esophageal Reflux Disease
          2. Inflammatory Bowel Disease
          3. Irritable Bowel Syndrome
        4. Nigeria Gastrointestinal Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacies
          3. Online Pharmacies
      11. Rest of MEA Gastrointestinal Drugs Market
        1. Rest of MEA Gastrointestinal Drugs Market By Drug Class Type 2022-2034 (USD MILLION/ Units)
          1. Acid Neutralizers
          2. Antidiarrheal and Laxatives
          3. Antiemetic and Antinauseants
          4. Anti-inflammatory Drugs
          5. Biologics
          6. Others (Antispasmodic etc.)
        2. Rest of MEA Gastrointestinal Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Intravenous
          3. Rectal
        3. Rest of MEA Gastrointestinal Drugs Market By Disorder Type 2022-2034 (USD MILLION/ Units)
          1. Gastro-esophageal Reflux Disease
          2. Inflammatory Bowel Disease
          3. Irritable Bowel Syndrome
        4. Rest of MEA Gastrointestinal Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacies
          3. Online Pharmacies
    5. LATAM
      1. LATAM Gastrointestinal Drugs Market By Drug Class Type 2022-2034 (USD MILLION/ Units)
        1. Acid Neutralizers
        2. Antidiarrheal and Laxatives
        3. Antiemetic and Antinauseants
        4. Anti-inflammatory Drugs
        5. Biologics
        6. Others (Antispasmodic etc.)
      2. LATAM Gastrointestinal Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous
        3. Rectal
      3. LATAM Gastrointestinal Drugs Market By Disorder Type 2022-2034 (USD MILLION/ Units)
        1. Gastro-esophageal Reflux Disease
        2. Inflammatory Bowel Disease
        3. Irritable Bowel Syndrome
      4. LATAM Gastrointestinal Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
      5. Brazil Gastrointestinal Drugs Market
        1. Brazil Gastrointestinal Drugs Market By Drug Class Type 2022-2034 (USD MILLION/ Units)
          1. Acid Neutralizers
          2. Antidiarrheal and Laxatives
          3. Antiemetic and Antinauseants
          4. Anti-inflammatory Drugs
          5. Biologics
          6. Others (Antispasmodic etc.)
        2. Brazil Gastrointestinal Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Intravenous
          3. Rectal
        3. Brazil Gastrointestinal Drugs Market By Disorder Type 2022-2034 (USD MILLION/ Units)
          1. Gastro-esophageal Reflux Disease
          2. Inflammatory Bowel Disease
          3. Irritable Bowel Syndrome
        4. Brazil Gastrointestinal Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacies
          3. Online Pharmacies
      6. Mexico Gastrointestinal Drugs Market
        1. Mexico Gastrointestinal Drugs Market By Drug Class Type 2022-2034 (USD MILLION/ Units)
          1. Acid Neutralizers
          2. Antidiarrheal and Laxatives
          3. Antiemetic and Antinauseants
          4. Anti-inflammatory Drugs
          5. Biologics
          6. Others (Antispasmodic etc.)
        2. Mexico Gastrointestinal Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Intravenous
          3. Rectal
        3. Mexico Gastrointestinal Drugs Market By Disorder Type 2022-2034 (USD MILLION/ Units)
          1. Gastro-esophageal Reflux Disease
          2. Inflammatory Bowel Disease
          3. Irritable Bowel Syndrome
        4. Mexico Gastrointestinal Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacies
          3. Online Pharmacies
      7. Argentina Gastrointestinal Drugs Market
        1. Argentina Gastrointestinal Drugs Market By Drug Class Type 2022-2034 (USD MILLION/ Units)
          1. Acid Neutralizers
          2. Antidiarrheal and Laxatives
          3. Antiemetic and Antinauseants
          4. Anti-inflammatory Drugs
          5. Biologics
          6. Others (Antispasmodic etc.)
        2. Argentina Gastrointestinal Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Intravenous
          3. Rectal
        3. Argentina Gastrointestinal Drugs Market By Disorder Type 2022-2034 (USD MILLION/ Units)
          1. Gastro-esophageal Reflux Disease
          2. Inflammatory Bowel Disease
          3. Irritable Bowel Syndrome
        4. Argentina Gastrointestinal Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacies
          3. Online Pharmacies
      8. Chile Gastrointestinal Drugs Market
        1. Chile Gastrointestinal Drugs Market By Drug Class Type 2022-2034 (USD MILLION/ Units)
          1. Acid Neutralizers
          2. Antidiarrheal and Laxatives
          3. Antiemetic and Antinauseants
          4. Anti-inflammatory Drugs
          5. Biologics
          6. Others (Antispasmodic etc.)
        2. Chile Gastrointestinal Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Intravenous
          3. Rectal
        3. Chile Gastrointestinal Drugs Market By Disorder Type 2022-2034 (USD MILLION/ Units)
          1. Gastro-esophageal Reflux Disease
          2. Inflammatory Bowel Disease
          3. Irritable Bowel Syndrome
        4. Chile Gastrointestinal Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacies
          3. Online Pharmacies
      9. Colombia Gastrointestinal Drugs Market
        1. Colombia Gastrointestinal Drugs Market By Drug Class Type 2022-2034 (USD MILLION/ Units)
          1. Acid Neutralizers
          2. Antidiarrheal and Laxatives
          3. Antiemetic and Antinauseants
          4. Anti-inflammatory Drugs
          5. Biologics
          6. Others (Antispasmodic etc.)
        2. Colombia Gastrointestinal Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Intravenous
          3. Rectal
        3. Colombia Gastrointestinal Drugs Market By Disorder Type 2022-2034 (USD MILLION/ Units)
          1. Gastro-esophageal Reflux Disease
          2. Inflammatory Bowel Disease
          3. Irritable Bowel Syndrome
        4. Colombia Gastrointestinal Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacies
          3. Online Pharmacies
      10. Rest of LATAM Gastrointestinal Drugs Market
        1. Rest of LATAM Gastrointestinal Drugs Market By Drug Class Type 2022-2034 (USD MILLION/ Units)
          1. Acid Neutralizers
          2. Antidiarrheal and Laxatives
          3. Antiemetic and Antinauseants
          4. Anti-inflammatory Drugs
          5. Biologics
          6. Others (Antispasmodic etc.)
        2. Rest of LATAM Gastrointestinal Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Intravenous
          3. Rectal
        3. Rest of LATAM Gastrointestinal Drugs Market By Disorder Type 2022-2034 (USD MILLION/ Units)
          1. Gastro-esophageal Reflux Disease
          2. Inflammatory Bowel Disease
          3. Irritable Bowel Syndrome
        4. Rest of LATAM Gastrointestinal Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacies
          3. Online Pharmacies
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on: